Can You Take Tramadol with Amitriptyline?

Severity assessment

Major. The combination significantly increases the risk of serotonin syndrome and seizures, both of which can be life-threatening.

Mechanism (plain English)

Both amitriptyline and tramadol affect chemical messengers in the brain, particularly serotonin and norepinephrine. Amitriptyline, a tricyclic antidepressant, increases the availability of these neurotransmitters. Tramadol, an opioid pain reliever, also increases serotonin and norepinephrine levels by inhibiting their reuptake. When taken together, the combined effect can lead to dangerously high levels of serotonin in the brain, causing a condition called serotonin syndrome. Additionally, both medications can lower the brain's seizure threshold, making seizures more likely.

Evidence level

Regulator-flagged. The FDA label for amitriptyline explicitly warns about the risk of serotonin syndrome with concomitant use of other serotonergic drugs, including tramadol [1]. The British National Formulary (BNF) also highlights the increased risk of hyponatremia and CNS effects with this combination [2].

Top regulator advisories (cite verbatim or close paraphrase)

• TGA (Australia): No pair-specific public advisory found. However, the TGA-approved product information for tramadol highlights the risk of serotonin syndrome when co-administered with other serotonergic agents [3].
• MHRA / NICE (UK): The British National Formulary (BNF) states that both tramadol and amitriptyline can increase the risk of hyponatremia and have additive effects on the central nervous system (CNS) [2]. NICE guidance on neuropathic pain also notes that the combination of tramadol with amitriptyline is associated with a low risk of serotonin syndrome [4].
• FDA / CDC (US): The FDA label for amitriptyline hydrochloride tablets states: "If concomitant use of amitriptyline hydrochloride with other serotonergic drugs, including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, ... is clinically warranted, observe patients for the emergence of serotonin syndrome" [1]. The FDA has also issued warnings about serotonin syndrome with opioid pain medicines, including tramadol [5].
• EMA (Europe): No specific EMA guidance found for this exact pair, but general warnings regarding serotonin syndrome with serotonergic drugs are applicable.

Clinical risk factors that elevate the danger

• Higher doses of either medication.
• Concomitant use of other serotonergic drugs (e.g., SSRIs, SNRIs, triptans, St. John's Wort).
• History of seizures or conditions that lower the seizure threshold (e.g., head trauma, CNS abnormalities, alcoholism).
• Elderly patients may be more susceptible to adverse effects due to altered metabolism and increased sensitivity.
• Impaired liver or kidney function, which can lead to higher drug levels.

What a patient should be told

• Understand the risk: Taking amitriptyline and tramadol together can lead to serious side effects like serotonin syndrome (confusion, agitation, sweating, muscle stiffness) and seizures. It's crucial to be aware of these risks.
• Do not stop suddenly: Never stop taking either medication or change your dose without talking to your doctor or pharmacist first. Suddenly stopping can lead to withdrawal symptoms or worsening of your condition.
• Watch for warning signs: Be alert for symptoms such as confusion, hallucinations, agitation, rapid heart rate, sweating, muscle twitching or stiffness, tremors, uncoordinated movements, nausea, vomiting, or diarrhea. Seek immediate medical attention if these occur.
• Discuss alternatives: Talk to your doctor or pharmacist about safer alternatives or strategies to manage your pain and mood with less risk. They can help adjust your treatment plan.
• Urgent care triggers: If you experience severe agitation, high fever, significant changes in blood pressure, or seizures, go to the nearest emergency room or call emergency services immediately.

Top 3 sources (with full citation)

1. U.S. Food and Drug Administration. Amitriptyline Hydrochloride Tablets, USP. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/085968s112lbl.pdf
2. NICE. British National Formulary (BNF): Tramadol. Available at: https://bnf.nice.org.uk/interactions/tramadol/
3. Therapeutic Goods Administration (TGA). Australian Public Assessment Report for Tramadol Hydrochloride. September 13, 2012. Available at: https://www.tga.gov.au/sites/default/files/auspar-tramadol-hydrochloride-120913.pdf

Notes for the reviewing pharmacist

The interaction between amitriptyline and tramadol primarily revolves around the heightened risk of serotonin syndrome and seizures due to their combined serotonergic and seizure-threshold-lowering effects. While some guidelines, like NICE, suggest a low risk of serotonin syndrome, the FDA and other sources indicate a more significant concern, especially with higher doses or in susceptible patients. Pharmacists should be vigilant for signs of serotonin syndrome and educate patients thoroughly on symptoms and when to seek urgent care. Consideration should be given to alternative pain management strategies or careful dose titration and monitoring if this combination is deemed necessary. The potential for hyponatremia and additive CNS depression also warrants attention.

Source metadata JSON

{
  "pair": "amitriptyline + tramadol",
  "severity": "Major",
  "evidence_level": "Regulator-flagged",
  "source_urls": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/085968s112lbl.pdf;https://bnf.nice.org.uk/interactions/tramadol/;https://www.tga.gov.au/sites/default/files/auspar-tramadol-hydrochloride-120913.pdf"
}